Adolor Corporation
Analgesics maker reports loss of $0.34 per share
Published in Lab Business Week, August 29th, 2004
For the 3 months ended June 30, 2004, the company reported a net loss of $13.0 million or $0.34 per basic and diluted share, compared to a net loss of $11.5 million or $0.36 per basic and diluted share in the 3 months ended June 30, 2003.
For the 6-month period ended June 30, 2004, the company reported a net loss of $23.3 million or $0.60 per basic and diluted share, compared to a net loss of $22.8 million or $0.72 per basic and diluted share for the same period in 2003.
"The second quarter was highlighted by the completion of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-08-29)
More Articles from Lab Business Week
- Abgenix, Inc.
Biotech company reports quarterly loss of $0.76 per share - Abiomed, Inc.
Cardiovascular device firm reports 47% increase in revenues - Accelrys, Inc.
IT company for biotech, pharma firms reports loss of $0.25 per share - Acusphere, Inc.
Drug development company reports $21.5M private financing - Advanced Medical Optics, Inc.
Ophthalmic surgical device maker reports 10.9% increase in revenue - Advanced Neuromodulation Systems, Inc.
Neuromodulation device maker reports net income increases 48% - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
